Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.470 | 2.470 | 0.000 |
Shares | 97.530 | 97.530 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 23.532 | 16.630 |
Price to Book | 2.308 | 1.940 |
Price to Sales | 1.889 | 1.154 |
Price to Cash Flow | 10.607 | 9.235 |
Dividend Yield | 0.836 | 2.455 |
5 Years Earnings Growth | 4.332 | 10.649 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 45.010 | 17.735 |
Technology | 32.390 | 15.596 |
Industrials | 12.120 | 27.221 |
Consumer Cyclical | 5.300 | 13.073 |
Communication Services | 2.710 | 5.334 |
Basic Materials | 1.580 | 5.355 |
Financial Services | 0.890 | 7.676 |
Number of long holdings: 63
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Efecte | FI4000282868 | 6.20 | 15.0500 | +0.67% | |
I.A.R Systems B | SE0005851706 | 4.55 | 170.00 | +1.49% | |
Envipco | NL0015000GX8 | 4.53 | 5.95 | +4.39% | |
MedCap | SE0009160872 | 4.39 | 502.000 | +0.40% | |
Swedencare | SE0015988167 | 4.11 | 59.25 | -0.92% | |
Aiforia Tech Oyj | FI4000507934 | 3.75 | 4.76 | 0.00% | |
Micro Systemations B | SE0000526626 | 3.10 | 48.00 | +0.63% | |
Stille AB | SE0000998650 | 3.03 | 217.00 | -0.46% | |
Biotage AB | SE0000454746 | 2.65 | 160.30 | +2.17% | |
Talenom Oyj | FI4000153580 | 2.63 | 4.80 | +2.13% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Aktia Capital A | 467.44M | 7.52 | -5.01 | 6.92 | ||
Aktia Capital B | 467.44M | 7.52 | -5.01 | 6.92 | ||
Aktia Solida A | 367.8M | 2.17 | -0.81 | 1.51 | ||
Aktia Solida B | 367.8M | 2.16 | -0.82 | 1.51 | ||
Aktia Secura B | 305.28M | 4.67 | -0.52 | 3.93 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review